Terug
Ook genoteerd als
GGNDF
OTC
Dagbereik
€ 44,51
€ 45,11
52-Weeksbereik
€ 36,83
€ 57,22
Volume
400
50D / 200D Gem.
€ 47,63
/
€ 49,03
Vorige Slotkoers
€ 43,90
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 3,3 | 0,4 |
| P/B | 0,2 | 2,9 |
| ROE % | 6,0 | 3,8 |
| Net Margin % | 3,9 | 3,9 |
| Rev Growth 5Y % | 1,6 | 10,0 |
| D/E | 1,0 | 0,2 |
Belangrijkste Punten
Revenue grew 1,56% annually over 5 years — modest growth
Earnings declined -33,91% over the past year
Generating 1,14B in free cash flow
P/E of 3,32 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,25%
Cash machine — converts 174,12% of earnings into free cash flow
Groei
Revenue Growth (5Y)
1,56%
Revenue (1Y)-6,69%
Earnings (1Y)-33,91%
FCF Growth (3Y)-2,90%
Kwaliteit
Return on Equity
6,01%
ROIC5,51%
Net Margin3,89%
Op. Margin9,51%
Veiligheid
Debt / Equity
0,99
Current Ratio1,18
Interest Coverage2,57
Waardering
P/E Ratio
3,32
P/B Ratio0,20
EV/EBITDA7,43
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,69% | Revenue Growth (3Y) | -3,76% |
| Earnings Growth (1Y) | -33,91% | Earnings Growth (3Y) | 69,23% |
| Revenue Growth (5Y) | 1,56% | Earnings Growth (5Y) | -21,91% |
| Profitability | |||
| Revenue (TTM) | 16,78B | Net Income (TTM) | 653,00M |
| ROE | 6,01% | ROA | 2,23% |
| Gross Margin | 54,56% | Operating Margin | 9,51% |
| Net Margin | 3,89% | Free Cash Flow (TTM) | 1,14B |
| ROIC | 5,51% | FCF Growth (3Y) | -2,90% |
| Safety | |||
| Debt / Equity | 0,99 | Current Ratio | 1,18 |
| Interest Coverage | 2,57 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 3,32 | P/B Ratio | 0,20 |
| P/S Ratio | 0,13 | PEG Ratio | -0,65 |
| EV/EBITDA | 7,43 | Dividend Yield | 0,01% |
| Market Cap | 2,17B | Enterprise Value | 11,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16,78B | 17,99B | 18,12B | 18,69B | 15,78B |
| Net Income | 653,00M | 988,00M | 228,00M | 511,00M | 1,76B |
| EPS (Diluted) | 12,93 | 20,34 | 4,92 | 11,97 | 40,47 |
| Gross Profit | 9,16B | 9,56B | 9,04B | 9,13B | 8,68B |
| Operating Income | 1,60B | 1,86B | 869,00M | 1,11B | 2,40B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,23B | 30,61B | 30,64B | 30,59B | 23,55B |
| Total Liabilities | 18,33B | 19,79B | 21,06B | 23,79B | 17,32B |
| Shareholders' Equity | 10,90B | 10,82B | 9,59B | 6,80B | 6,23B |
| Total Debt | 10,82B | 11,49B | 13,50B | 16,25B | 11,57B |
| Cash & Equivalents | 1,12B | 980,00M | 2,16B | 990,00M | 6,21B |
| Current Assets | 8,64B | 9,33B | 10,18B | 9,37B | 11,99B |
| Current Liabilities | 7,32B | 8,15B | 15,64B | 11,73B | 6,14B |